Hua Rong, Lu, M.D., Ph.D. is a Scientific Director for in vitro cardiac and neuronal safety in Safety Pharmacological Research at Janssen Pharmaceutical. He has a broad and deep scientific knowledge with more than 30 years of experiences in cardiovascular drug discovery and safety pharmacology research both in vitro and in vivo. He obtained an MD in in China and worked as Physician in the Peking Medical College Hospital from 1985 to 1987. He later emigrated to Belgium to complete a PhD in Cardiovascular Research at the KU Leuven (KUL) in Belgium. He has new medicine Research and Development experience and led large scientific projects internationally. He has more than 90 full publications in cardiovascular and safety research. Currently, he is also responsible for the strategic evaluation of a new platform using human-stem-cell-derived cardiomyocytes and neuronal cells, which could potentially replace a number of preclinical in vitro tests. He was also actively involved in HESI-CIPA and HESI-MEA for drug-induced seizures using HiPS cells.